At a glance
- Originator Zambon Group SpA
- Class Antihypertensives; Heart failure therapies
- Mechanism of Action Dopamine D1 receptor agonists; Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 11 Jun 1999 Discontinued-Preclinical for Congestive heart failure in Italy (Unknown route)
- 11 Jun 1999 Discontinued-Preclinical for Hypertension in Italy (Unknown route)
- 19 Sep 1997 New profile